课题基金 / 基金详情

Roles of PI 3-kinase isoforms in autophagy and endosomal membrane dynamics

Roles of PI 3-kinase isoforms in autophagy and endosomal membrane dynamics
PI 3-激酶亚型在自噬和内体膜动力学中的作用
批准号:
G0700755/1
负责人:
Bart Vanhaesebroeck
金额:
$47.05万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Bart Vanhaesebroeck的其他基金

相似基金

相关文献

中文摘要
翻译
人体最基本的组成部分之一是称为细胞的结构。每个细胞都被一层脂肪膜包围着,这层脂肪膜保持着细胞与周围环境分离的特性。此外,每个细胞本身被细分成更多的室室,其中包含称为细胞器的离散和独特的膜结合结构。为了使细胞发挥功能,它必须能够发挥多种作用,包括与细胞外环境的通信,细胞器之间物质的调节转移以及细胞内老化物质的再循环。这些功能的任何缺陷都可能导致畸变,最终导致细胞功能失常,导致癌症,细胞不受控制的生长。我们的实验室研究细胞内的催化剂,称为pi3k。pi3k能够特异性地操纵细胞膜的组成。这些操作对于确保细胞器之间以及外部环境与细胞器之间的物质转移的保真度至关重要。这些pi3k在维持正常细胞功能方面的重要性,在高比例的肿瘤中受到损害。因此,很明显,如果我们希望解决癌症的原因,并试图治愈癌症患者,了解pi3k在整个生物体中的功能是至关重要的。然而,这种研究方法的主要问题在于细胞内存在多种PI3K,每种PI3K在细胞内发挥不同的作用。为此,我们的实验室产生了小鼠模型,其中在细胞水平和整个生物体水平上特异性地消融离散pi3k的活性。通过这种方法,我们能够为每个PI3K分配特定的作用,并与制药公司联合设计针对每个PI3K的小分子抑制剂。然后,这些小分子抑制剂将在定向实验中进行测试,以确定它们在治疗癌症和其他由PI3K信号缺陷引起的健康问题方面是否有任何治疗用途。
英文摘要
One of the most fundamental component parts of the human body is a structure termed a cell. Every cell is surrounded by a membrane of fat which maintains its identity separate from the surrounding environment. Furthermore, every cell is subdivided into more compartments by itself containing discrete and unique membrane-bound structures termed organelles. In order for a cell to function it must be able to perform a number of roles including communication with the extracellular milieu, the regulated transfer of material between organelles and the recycling of aged material within the cell itself. Defects in any of these functions can lead to abberations which ultimately cause the cell to malfunction and lead to cancer, the unregulated growth of cells. Our laboratory works on catalysts within the cell termed PI3Ks. PI3Ks are able to specifically manipulate the composition of the cellular membranes. These manipulations are critical to ensure fidelity of the transfer of material between organelles and between the external environment and organelles. The importance of these PI3Ks in maintaining normal cellular functions is highlighted by the fact that they are compromised in a high percentage of tumors. Consequently it is obvious that if we wish to tackle the causes of cancer and try to cure patients suffering from cancer it is vital that we know how PI3Ks function in whole organisms. The main problem with this avenue of enquiry however is that there are numerous flavors of PI3K within cells and each performs a distinct role within the cell. To this end our laboratory generate mice models where the activity of discrete PI3Ks are specifically ablated, both at the level of cells and the whole organism. By this methodology we are able to assign specific roles to each PI3K and in combination with drug companies design small molecule inhibitors targeted towards each PI3K. These small molecule inhibitors are then tested in directed experiments to see whether they will be of any therapeutic use in tackling cancer and other health issues arising from defective PI3K signalling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integration of lipid and protein kinase signalling in primary cilia biology
  • 批准号:
    BB/W007460/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.23万
  • 财政年份:
    2022
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Designing modulators of PI 3-kinase delta (PI3Kdelta) for the treatment of haematological malignancies
  • 批准号:
    MC_PC_MR/S02607X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $7.55万
  • 财政年份:
    2019
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Isoforms of PI 3-kinase as novel regulators of dsRNA-sensing and inflammation
  • 批准号:
    BB/R017972/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.47万
  • 财政年份:
    2018
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization
  • 批准号:
    BB/M013278/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $15.7万
  • 财政年份:
    2016
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
国内基金
海外基金
第452位络氨酸磷酸化PI3Kp85抗体的制备方法和使用方法
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    迟寅秀
  • 依托单位:
NCAPD2通过PI3K-AKT-mTOR-Myc信号轴促进子宫内膜样癌增殖及EMT的机制与靶向治疗研究
  • 批准号:
    JCZRLH202600400
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于“痞积转化”理论探究网果酸模通过PI3K/Akt通路调控巨噬细胞极化平衡抑制胃癌的分子机制​
“补肾健脾,化痰通络”法调控PI3K/Akt/MCT1介导的乳酸转运改善血管性痴呆的机制研究